Leanna M. Levine, Ph.D.
Dr. Levine, founder of ALine, Inc., is an entrepreneur, technologist, and inventor. She has a unique blend of technical expertise in both bioanalytical science and manufacturing process development. Developing processes for rapid prototyping and manufacture of microfluidic devices was her founding vision. Prior to founding ALine, Dr. Levine developed bioanalytical technology to support life science research. While at Monsanto, her lab led the industry in the application of fluorescence polarization for high throughput screening for novel therapeutics. In 1998 she joined Spectrum Laboratories as Director of Hollow Fiber Manufacture and Product Development. Dr. Levine earned her Ph.D. at Washington University, St. Louis, MO , and her B.S. in Biochemistry and BA in German from the University of Missouri, Columbia, MO. In 2003 she was a visiting scholar at the UCLA Anderson School of Business. In 2000 she was the chair of the Gordon Conference on Bioanalytical Sensors. She is the co-author on a dozen publications, and several patents.
Stefano Begolo, Ph.D.
Stefano Begolo has been a key player in the development of the patented microfluidic slip-chip technology for medical diagnostic applications while at the California Institute of Technology. Stefano has expertise in the design and development of 3D printed microfluidic components, and specialized skills in embossing, lithography, and UV cure laminate devices. His materials expertise ensures the incorporation of surfaces compatible with a variety of biomolecular interactions and specialized fluidic functions. He earned his Ph.D. in Physics in 2011 from the Université Pierre et Marie Curie (Paris VI). He obtained a B.S. in Material Science and a M.S. in Material Science and Engineering from the University of Padua (Italy). His graduate work focused on the use of droplet microfluidics for detecting DNA and proteins, and on the development of innovative technologies for the production of microfluidic devices. He is co-author of seven publications and several patents.
Francesca Yu, B.S.
Francesca has a BS in Biomedical Engineering from the University of California, Irvine. She has taken the lead in developing and managing ALine's Quality System to achieve ISO 13485 certification. She manages the fabrication floor, and is in charge of training for all fabrication technicians. An expert in ALine's fabrication techniques and developing fabrication instruction files, Francesca ensures parts meet ALine's quality objectives and ensures shipments are on time and high quality with as little stress as possible.
Lamar Glover, M.S.
Lamar Glover earned his M.S. in Physics at Cal State Los Angeles with a research background in optics and material science. Joining the ALine team in 2018, he focuses on engineering support by providing design guidance for custom microfluidic devices. He is the co-author of two publications.
Board of Directors
Neelima Firth, MBA
Neelima Firth is an innovative Senior Executive and Board Member with more than 30 years of success spanning biotechnology, pharmaceuticals, and medical devices. Leveraging extensive experience in strategic leadership in life science organizations, Neelima provides insight into leadership and commercialization strategies. Her broad areas of expertise include problem solving, big picture perspective, marketing and commercialization, strategic planning, project management, financial forecasting, and business development. Neelima has held leadership positions with Amgen, the Alfred Mann Foundation, Bristol Myers Squibb and GSK.
Atul Jhalani is a senior executive leader, board member, entrepreneur, and strategist with more than 25 years of experience in start-up and public companies. Expert at identifying market opportunities, commercializing innovative products, negotiating key contracts, developing distribution channels, building direct sales, creating OEM partnerships and generating revenue. Skilled at strategic planning, supplier management, engineering and mergers and acquisitions. Exceptional at solving intractable problems, changing business models, managing diverse cultures, building and motivating teams that dramatically grow the top line and bottom line of companies. Atul has held leadership positions with Paramit, BMEYE, Masimo and Philips.
Science Advisory Board
Antonio J. Ricco, Ph.D.
Antonio J. Ricco is Chief Technologist for Small Spacecraft Payloads and Technologies at NASA's Ames Research Center, on leave from Stanford University. Ricco received B.S. and Ph.D. degrees in Chemistry from the University of California at Berkeley (1980) and the Massachusetts Institute of Technology (1984). He developed chemical microsensor technologies and systems at Sandia National Laboratories from 1984 to 1998. From 1999 to 2003 at ACLARA BioSciences, he led development of single-use plastic microfluidic systems for genetic analysis, high-throughput pharmaceutical discovery, proteomics, and pathogen detection. He was Director of Stanford's National Center for Space Biological Technologies from 2004 to 2007; since 2007, he has been at NASA's Ames Research Center, on leave from Stanford. Dr. Ricco is the co-author of over 200 presentations, 140 publications, and a dozen patents. He is a Fellow of The Electrochemical Society, past Chair of the Sensor Division of The Electrochemical Society, and a recipient of that division's Outstanding Achievement Award.
Fernando Cruz-Guilloty, Ph.D.
Fernando is a Scientific Consultant with 10 years of experience in a broad range of biomedical research areas in both academic and industry settings, focusing primarily on the fields of immunology, biomarkers and assay development. An effective communicator, Fernando develops working interactions within cross-functional teams, providing executive management with key decision-making R&D perspectives. His contributions include setting up a variety of multidisciplinary collaborations (academia, industry, consulting, CROs) to achieve project goals. At DxTerity, Fernando served as Principal Scientist in personalized medicine, working to develop first-in-class gene expression diagnostics in a broad disease spectrum (autoimmune disease and immuno-oncology). Previously, he led R&D efforts at Immucor to transition innovative academic research into a next-generation platform in blood typing and diagnostics. His experience includes Design Control procedures at different stages of the FDA regulatory approval process. Fernando obtained a B.S. degree in Industrial Biotechnology from the University of Puerto Rico-Mayaguez and a Ph.D. from Harvard Medical School, where his research focused on basic transcriptional and epigenetic studies of the immune system. During postdoctoral studies at the Bascom Palmer Eye Institute, he studied the interaction of innate and adaptive immunity in age-related macular degeneration, a major blinding disease. As an independent investigator, he initiated immuno-oncology projects on breast cancer and melanoma. Fernando is also actively involved as a mentor with programs aimed at increasing diversity within STEM fields.